Wedbush Securities’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Hold
0
– -$4K – 1083
2022
Q3
– Hold
0
– – – 1040
2022
Q2
– Hold
0
– – – 1062
2022
Q1
– Hold
0
– – – 1086
2021
Q4
– Hold
0
– – – 1161
2021
Q3
– Sell
-1
Closed -$259K – 1142
2021
Q2
$291K Hold
1
– – 0.01% 880
2021
Q1
$370K Buy
+1
New +$586K 0.02% 707
2020
Q4
– Sell
-2
Closed -$1.13M – 808
2020
Q3
$1.32M Buy
2
+1
+100% +$690K 0.13% 170
2020
Q2
$1.13M Sell
1
-1
-50% -$850K 0.11% 198
2020
Q1
$1M Hold
2
– – 0.12% 176
2019
Q4
$578K Buy
2
+1
+100% +$290K 0.05% 411
2019
Q3
$340K Buy
+1
New +$365K 0.03% 588
2019
Q2
– Sell
-2
Closed -$994K – 786
2019
Q1
$969K Hold
2
– – 0.1% 230
2018
Q4
$589K Hold
2
– – 0.08% 305
2018
Q3
$1.14M Buy
2
+1
+100% +$914K 0.13% 184
2018
Q2
$775K Buy
+1
New +$1.15M 0.1% 242
2018
Q1
– Hold
0
– – – 367
2017
Q4
– Hold
0
– – – 375

Other funds holding KALA

Wedbush Securities's KALA Position: Q4 2022 in Review

Wedbush Securities held its KALA BIO (KALA) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Wedbush Securities first reported a position in KALA in Q2 2018 and has held it in 11 quarters since. The position peaked at $1.32M in Q3 2020. 16 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • Wedbush Securities held 0 shares of KALA BIO worth $0 as of Q4 2022.
  • Wedbush Securities left its KALA BIO share count unchanged in Q4 2022.
  • KALA BIO made up ﹤0.01% of Wedbush Securities's portfolio in Q4 2022, its #1083 holding.
  • Wedbush Securities first reported a position in KALA BIO in Q2 2018 and has held it in 11 quarters since.
  • Wedbush Securities's KALA BIO position peaked at $1.32M in Q3 2020.
  • 16 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Wedbush Securities's 13F filing for Q4 2022, filed 31 Jan 2023.